Cat No.
CEI-0083
Description
Wortmannin can inhibit MLCK and PI3K with IC50 of 0.17 uM and 3 nM.
Alias
KY 12420
Synonyms
KY 12420
CAS No.
19545-26-7
Targets
MLCK, PI3K
Chemical Name
3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione, 11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, (1S,6bR,9aS,11R,11bR)-
M.Wt
428.43
Purity
>99%
Solubility
DSMO 86 mg/mL Water
Storage
2 years at -20 centigrade
In vitro
Wortmannin directly interacts with the catalytic domain of MLCK and leads to an irreversible loss of the enzyme activity. Wortmannin inhibits N-formylmethionyl-leucylphenylalanine (fMLP)-stimulated PtdInsP3 formation with IC50 of 5 nM and this inhibition is completely abolished when pretreated with 100 nM Wortmannin in human neutrophils.
In vivo
Wortmannin inhibits phosphatidylinositide 3-kinase-protein kinase B (PKB)/Akt phosphorylation in both normal tissues (lung, heart and brain homogenates) and tumor tissue in mice, without mortality or acute toxicity at 0.7 mg/kg.
